Organogenesis Q2 Revenue Surpasses Forecasts at $130M
Organogenesis exceeds Q2 revenue expectations at $130.2M, driven by robust sales and strategic growth plans.
- Latest
- Trending
Organogenesis exceeds Q2 revenue expectations at $130.2M, driven by robust sales and strategic growth plans.
Energy Aspects sees no imminent US recession despite global concerns, forecasting stable oil fundamentals and balanced markets.
U.S. investors turn to money market funds, shedding stocks, amid economic slowdown fears and disappointing data.
SoundHound AI shares surge 21% after acquiring Amelia, but drop post earnings. Watch key price levels.
US stock futures steady as jobless claims drop, sparking Wall St rebound. Attention shifts to upcoming US inflation data.
Explore how the NIS2 Directive impacts cybersecurity innovation and compliance across Europe with new regulatory standards.
Robinhood responds to SEC Wells Notice amid crypto business scrutiny, highlighting ongoing retail trading popularity.
Moody's downgrades Intel's rating to BAA1, citing profitability concerns and changes outlook to negative.
Banxico lowers interest rate to 10.75%, while inflation expectations rise. Analysts question the central bank's decision.
Recent stock volatility disrupts options strategies that thrived on earnings-fueled swings, affecting profitability.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.